Accustem Sciences Inc. financial data

Symbol
ACUT on OTC
Location
5 Penn Plaza, 19 Th Floor, #1954, New York, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 22.9 % +306%
Debt-to-equity -130 % -22.2%
Return On Equity 55.1 % -20.7%
Return On Assets -186 % +83.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 16.1M shares
Common Stock, Shares, Outstanding 16.1M shares +41.6%
Common Stock, Value, Issued 16.1K USD +41.7%
Weighted Average Number of Shares Outstanding, Basic 16.1M shares +41.6%
Weighted Average Number of Shares Outstanding, Diluted 16.1M shares +41.6%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 162K USD -7.17%
General and Administrative Expense 1.38M USD -6.43%
Operating Income (Loss) -1.54M USD +6.51%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.54M USD +6.51%
Net Income (Loss) Attributable to Parent -1.54M USD +6.51%
Earnings Per Share, Basic 0 USD/shares +26.7%
Earnings Per Share, Diluted 0 USD/shares +26.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Other Assets, Current 1.5M USD
Assets, Current 1.61M USD +1074%
Property, Plant and Equipment, Net 105 USD -96.7%
Assets 1.61M USD +1055%
Accounts Payable, Current 860K USD +15.5%
Accrued Liabilities, Current 154K USD -0.69%
Liabilities, Current 4.15M USD +37.2%
Liabilities 4.15M USD +37.2%
Retained Earnings (Accumulated Deficit) -8.87M USD -21%
Stockholders' Equity Attributable to Parent -2.53M USD +12.1%
Liabilities and Equity 1.61M USD +1055%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -290K USD -22.3%
Net Cash Provided by (Used in) Financing Activities 322K USD +42.7%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 16.1M shares +41.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 31.3K USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 336 USD -51.8%
Deferred Tax Assets, Valuation Allowance 1.74M USD +28%
Depreciation 2.23K USD -38.5%
Property, Plant and Equipment, Gross 11K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 1.59M USD +29.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 6.32M USD +42.6%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.74M USD +28%
Share-based Payment Arrangement, Expense 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%